FMR LLC discloses 8.2% Crocs (CROX) stake in amended 13G
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
FMR LLC filed an amended Schedule 13G reporting a significant ownership stake in Crocs, Inc. common stock as of 12/31/2025. FMR LLC and Abigail P. Johnson are each reported as beneficially owning 4,233,828.76 shares, representing 8.2% of Crocs’ common stock.
FMR LLC is shown with sole voting power over 4,080,252.89 shares and sole dispositive power over 4,233,828.76 shares, while Johnson has sole dispositive power over the same 4,233,828.76 shares. The filing states the holdings are kept in the ordinary course of business and not for the purpose of changing or influencing control of Crocs.
Positive
- None.
Negative
- None.
FAQ
What ownership stake in CROX does FMR LLC report in this Schedule 13G/A?
FMR LLC reports beneficial ownership of 4,233,828.76 shares of Crocs common stock, representing 8.2% of the class. This makes FMR LLC a significant institutional holder under SEC rules requiring disclosure above the 5% threshold.
How much of Crocs (CROX) stock does Abigail P. Johnson beneficially own?
Abigail P. Johnson is reported as beneficially owning 4,233,828.76 shares of Crocs common stock, equal to 8.2% of the class. She has sole dispositive power over these shares, according to the Schedule 13G/A filing.
Does FMR LLC seek to influence control of Crocs (CROX) with this stake?
The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Crocs. It also notes they are not held in connection with any control-related transaction.
Why is this Schedule 13G/A amendment important for Crocs (CROX) investors?
The amendment updates investors on a large institutional holder’s position, confirming FMR LLC and Abigail P. Johnson together beneficially own 8.2% of Crocs’ common stock. It also confirms the position is held in the ordinary course, not to influence corporate control.